ArticleIrish journal of medical science2017
Can oral isotretinoin be safely initiated and monitored in primary care? A case series.
Article in Irish journal of medical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Acne management in Norway: GP and dermatologist prescriptions (2012-2019): a nationwide overview.BJGP open · 2025Article
- Prescribing Trends for Acne Vulgaris Visits in the United States.Antibiotics (Basel, Switzerland) · 2023Article
- The management of acne vulgaris in young people in primary care: A retrospective cohort study.Frontiers in medicine · 2023Article
- GPs' practice and attitudes to initiating isotretinoin for acne vulgaris in Ireland: a cross-sectional questionnaire survey in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral isotretinoin has traditionally been prescribed only in secondary care for severe or resistant acne.
aimsTo explore whether this drug can be safely initiated and monitored in primary care by a GP with extra training in dermatology.
methodOne hundred consecutive patients who were started on oral isotretinoin therapy in a primary care centre were retrospectively reviewed.
resultsOne hundred percent of the patients with acne who completed their course of isotretinoin were cleared at the end of treatment. Twenty-three of the eighty-one patients (28%) who were followed-up after a mean of 5 years relapsed and eighteen (22%) had to have at least one more course of isotretinoin. Seventy-four of seventy-seven (96%) patients who had long-term follow-up were satisfied with the level of care they received in primary care.
conclusionThis study suggests that oral isotretinoin can be safely initiated and monitored by a GP with a special interest in dermatology and experience in prescribing systemic retinoids.
Indexed as
Identifiers
28070816What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.